text_1: In patients with congenital heart defects, β-blockers significantly improve clinical heart failure outcomes.
text_2: A prespecified subgroup analysis noted significant interaction between treatment and ventricular morphology (P = .02), indicating a possible differential effect of treatment between patients with a systemic left ventricle (beneficial trend) and those whose systemic ventricle was not a left ventricle (nonbeneficial trend).